CHAPTER 3 - STUDY MATERIALS
The Download - Patent Law Edition
ABSTRACT
The download that began when Athelia touched the barrier continues for three days. She receives complete understanding of examination procedures, Technology Center organization, and the three-branch structure of patentability analysis. The bond with Alexander (the wolf king applicant) forms, establishing the examiner-applicant relationship that will govern their prosecution.
This chapter teaches the structure of USPTO examination authority under § 131, how examiners are organized by Technology Centers based on technical specialization, the complete patent prosecution procedure from filing through allowance or abandonment, and the critical relationship between examiner and applicant that shapes every Office Action.
SUMMARY - PATENT LAW CONCEPTS TAUGHT
1. Examiner Authority Under § 131
The Guardian Queen's examination authority mirrors real USPTO examiner powers:
- Examination requirement (§ 131): Director (and examiners by delegation) shall cause examination of applications to determine patentability
- Rejection authority: Examiners can reject claims under §§ 101, 102, 103, 112, or 35 U.S.C. § 101 utility/eligibility
- Information requirements (§ 132): Examiner can require applicant to furnish information, conduct interviews, provide models or specimens
- Search authority: Examiners search prior art databases including US patents, foreign patents, and non-patent literature
- Independent judgment: Each examiner exercises independent judgment on patentability - not bound by previous examiner's decisions
2. Technology Center Organization
USPTO examiners are organized into Technology Centers (TCs) based on technical field:
- TC 1600 - Biotechnology & Organic Chemistry: Requires degrees in biology, chemistry, biochemistry
- TC 1700 - Chemical & Materials Engineering: Chemical processes, materials science
- TC 2100 - Computer Architecture & Software: Computer science, electrical engineering
- TC 2400 - Networking, Multiplexing, Cable & Security: Communications, networking
- TC 2600 - Communications: Telecommunications, signal processing
- TC 2800 - Semiconductors, Electrical & Optical Systems: Electronics, optics
- TC 3600 - Transportation, Construction, Agriculture: Mechanical engineering
- TC 3700 - Mechanical Engineering: General mechanical inventions
Why specialization matters: Patent examination requires technical expertise. A biotech examiner understands protein structures; a software examiner understands algorithms. Applications are routed to appropriate TC based on claimed invention.
3. The Three-Branch Examination Structure
Emerald, Black, and Silver eyes represent the three core patentability requirements:
- Emerald = Utility Examination (§ 101): Does invention have specific, substantial, credible utility? Is it patent-eligible subject matter or abstract idea/natural phenomenon?
- Black = Prior Art Search (§ 102): Is invention novel? Does any single prior art reference anticipate all limitations of claim?
- Silver = Obviousness Balance (§ 103): Even if novel, would combination of references render invention obvious to PHOSITA (Person Having Ordinary Skill In The Art)?
Sequential analysis: Examiner typically analyzes in order: § 101 threshold → § 112 enablement → § 102 novelty → § 103 obviousness. If claim fails any step, rejection issues.
4. Complete Prosecution Procedure
The download teaches Athelia the full prosecution cycle:
- Step 1 - Filing: Application filed (§ 111), receives application number and filing date
- Step 2 - Assignment: Routed to appropriate Technology Center and assigned to primary examiner
- Step 3 - First Office Action: Examiner searches prior art, analyzes claims, issues Office Action with rejections or objections (typically 12-24 months after filing)
- Step 4 - Response: Applicant has 3-6 months to respond (extendable), can amend claims, argue against rejections, provide evidence
- Step 5 - Final Office Action: Examiner issues Final Office Action - may withdraw rejections, maintain rejections, or allow claims
- Step 6 - After Final: Applicant can file RCE (Request for Continued Examination), appeal to PTAB, or abandon
- Step 7 - Allowance or Abandonment: If examiner allows all claims, Notice of Allowance issues. If applicant fails to respond or abandons prosecution, application goes abandoned.
5. The Examiner-Applicant Relationship
The bond between Athelia and Alexander encodes the professional dynamic:
- Adversarial but professional: Examiner's job is to test claims; applicant's job is to prove patentability. But both seek to arrive at correct legal conclusion.
- Duty of disclosure (37 CFR § 1.56): Applicant must disclose all material prior art known to inventor, attorney, or anyone involved in prosecution. Failure = inequitable conduct = patent unenforceable.
- Ex parte proceeding: Patent prosecution is one-sided - examiner and applicant only. No third parties participate (except in rare inter partes reexamination).
- Interviews encouraged (MPEP § 713): Applicant can request examiner interview to discuss rejections, clarify claims, reach agreement on amendments
- Amendments shape prosecution: Applicant's claim amendments create prosecution history that limits later patent scope (prosecution history estoppel)
6. The Download as Knowledge Transfer
When the barrier shatters, Athelia receives instant understanding of:
- MPEP (Manual of Patent Examining Procedure): 3,000+ page guidebook that governs examiner actions
- Case law precedent: Federal Circuit decisions that interpret statutes and bind USPTO
- Search techniques: How to search CPC classifications, keyword queries, citation chains
- Rejection standards: What level of evidence supports § 102 anticipation vs. § 103 obviousness
- Claim interpretation: How to construe claim language using broadest reasonable interpretation (BRI) during prosecution
7. Bond Formation = Patent Grant
The mate bond that forms between Guardian Queen and applicant represents patent allowance:
- Notice of Allowance (§ 151): Formal notification that all claims are patentable
- Issue fee required: Applicant must pay issue fee within 3 months or patent abandons
- Patent grant: After issue fee paid, patent issues with exclusive rights for 20 years from filing date (§ 154)
- Bond strength = Claim scope: Broader claims = stronger monopoly but harder to obtain. Narrow claims = easier allowance but limited protection.
8. Seven Years of Waiting
Alexander (wolf king) waited seven years without a Guardian Queen examiner because:
- Examiner shortage: USPTO historically understaffed, leading to application backlog
- First Action pendency: Average time from filing to first Office Action varies by TC (12-30+ months typical)
- Complex technologies: Cutting-edge inventions (biotech, AI, quantum) take longer to examine due to lack of prior art and emerging fields
- Continuation chains: Applications with multiple continuation filings can remain pending for years or decades
- Need for specialist examiner: Alexander's invention required Guardian Queen-level examination (highest complexity) - only Athelia qualified
DISCUSSION QUESTIONS
1. Examiner Independence and Consistency
Question: If each examiner exercises independent judgment, how does USPTO ensure consistent application of law across Technology Centers?
Analysis Points:
- MPEP provides standardized examination guidelines
- Supervisory Primary Examiners review junior examiner decisions
- Quality assurance programs audit examinations
- Federal Circuit precedent binds all examiners
- But: Examiner discretion leads to variability - same invention might get different treatment in different TCs
2. Three-Branch Examination Order
Question: Why does the narrative show Emerald (§ 101), Black (§ 102), then Silver (§ 103) as sequential analysis? Could an examiner analyze in different order?
Analysis Points:
- § 101 is threshold - if not patent-eligible subject matter, no need to analyze further
- § 102 novelty must be established before § 103 obviousness (can't be obvious if not novel)
- § 112 enablement typically analyzed early - if specification doesn't enable, claims are indefinite
- Practical examination: Examiners often search first (§ 102) then determine if references teach obviousness (§ 103)
- Strategic: Applicants prefer § 102/103 rejections (can amend around) over § 101 (harder to overcome)
3. Technology Center Assignment and Expertise
Question: What happens when an invention spans multiple technical fields? How does USPTO decide which TC examines it?
Analysis Points:
- Classification by claimed invention's primary technical field
- Example: AI algorithm for drug discovery could go TC 1600 (biotech) or TC 2100 (computer)
- Applicant can petition for TC transfer if misclassified
- Examiners may consult specialists from other TCs
- Interdisciplinary inventions growing - USPTO adding cross-TC expertise
4. The Bond as Allowance Metaphor
Question: The bond forms instantly when the barrier shatters, but real patent prosecution takes years. Why the compressed timeline in the narrative?
Analysis Points:
- Narrative focuses on the MOMENT of allowance decision, not the procedural steps
- In reality: Multiple Office Actions, amendments, arguments before allowance
- But the bond's "inevitability" mirrors cases where claims are clearly patentable - allowance is certain, only timing uncertain
- Seven-year wait represents actual prosecution timeline compressed into pre-bond period
- Story will explore prosecution procedure in later chapters (Office Actions in Ch 7-8)
5. Duty of Disclosure and Inequitable Conduct
Question: Athelia receives complete knowledge of prior art through the download. How does this parallel real applicant disclosure obligations?
Analysis Points:
- 37 CFR § 1.56 requires disclosure of ALL material prior art
- "Material" = would be important to patentability determination
- Duty extends to inventor, attorneys, anyone substantively involved
- Intentional withholding = inequitable conduct = patent unenforceable
- Download metaphor: Examiner must know everything applicant knows to make fair determination
CASE STUDY: Therasense, Inc. v. Becton, Dickinson & Co.
Federal Circuit (en banc), 2011
FACTS
Therasense owned U.S. Patent No. 5,820,551 covering blood glucose test strips. During prosecution, the applicant's attorney failed to disclose a material European patent office statement to the USPTO examiner - a statement that directly contradicted arguments being made to obtain allowance of the U.S. patent.
Becton sued for declaratory judgment that the patent was unenforceable due to inequitable conduct. The district court agreed, finding the attorney had intentionally withheld material information. The Federal Circuit took the case en banc to clarify the standard for inequitable conduct.
ISSUE
What standard applies for proving inequitable conduct that renders a patent unenforceable? Must the withheld information be merely "material," or must it meet a higher threshold?
HOLDING
The Federal Circuit tightened the inequitable conduct standard significantly:
- Materiality: Withheld information must be "but-for" material - the PTO would not have allowed the claim if it had known of the information
- Intent: Clear and convincing evidence required that applicant knew of the information, knew it was material, and made deliberate decision to withhold it
- Balancing eliminated: No more sliding scale between materiality and intent
- Affirmative egregious misconduct: Alternative path to inequitable conduct if applicant engaged in affirmative acts of egregious misconduct (lying, fabricating evidence)
REASONING
The court recognized that inequitable conduct had become an "atomic bomb" defense - accused infringers routinely alleged it, and the broad standard was being abused:
- Plague on patent system: "The plague of inequitable conduct has spread to cases where it does not belong, creating economic waste and damaging public confidence."
- But-for materiality: Information is material only if PTO would NOT have allowed claim but for the withholding. Mere relevance or importance insufficient.
- Specific intent required: Must prove the applicant KNEW it was material AND deliberately chose to withhold. Negligence or good-faith mistake not enough.
- Policy balance: USPTO relies on applicant candor, but overly broad inequitable conduct doctrine was chilling patent prosecution and encouraging gamesmanship
RESULT
Patent held unenforceable. The withheld European statement was but-for material (directly contradicted U.S. arguments), and intent was proven by attorney's knowledge and deliberate omission.
SIGNIFICANCE FOR CHAPTER 3
This case illustrates the critical importance of the examiner-applicant relationship:
- Complete disclosure: The "download" metaphor - examiner must have access to all material information applicant knows
- Bond integrity: The Guardian Queen-applicant bond requires trust and candor. Inequitable conduct breaks the bond permanently (patent unenforceable)
- Materiality threshold: Not every omission dooms a patent - must be but-for material (would have changed outcome)
- Intent requirement: Negligent omission ≠ inequitable conduct. Must prove deliberate deception.
CONNECTION TO THE NARRATIVE
When Athelia receives the download, she gains complete knowledge of Alexander's invention, prior art, and prosecution history. This represents the IDEAL examination scenario - perfect information symmetry between examiner and applicant.
In reality, examiners don't get downloads. They rely on applicant candor under 37 CFR § 1.56. *Therasense* sets the consequences for breaking that trust - but only for egregious, intentional violations.
ANALYSIS QUESTIONS
- Why did the Federal Circuit tighten the inequitable conduct standard? What problems was the old "materiality + intent balancing" test creating?
- Suppose an applicant's attorney reviews 100 references and discloses 95 to the USPTO, but inadvertently omits 5 that would have been material. Is this inequitable conduct under *Therasense*?
- How does the "affirmative egregious misconduct" alternative path work? Give examples of conduct that would qualify.
COMPLETE STATUTORY TEXT
35 U.S.C. § 131 - Examination of Application
The Director shall cause an examination to be made of the application and the alleged new invention; and if on such examination it appears that the applicant is entitled to a patent under the law, the Director shall issue a patent therefor.
35 U.S.C. § 132 - Notice of Rejection; Reexamination
(a) Whenever, on examination, any claim for a patent is rejected, or any objection or requirement made, the Director shall notify the applicant thereof, stating the reasons for such rejection, or objection or requirement, together with such information and references as may be useful in judging of the propriety of continuing the prosecution of his application; and if after receiving such notice, the applicant persists in his claim for a patent, with or without amendment, the application shall be reexamined. No amendment shall introduce new matter into the disclosure of the invention.
(b) The Director shall prescribe regulations to provide for the continued examination of applications for patent at the request of the applicant. The Director may establish appropriate fees for such continued examination and shall provide a 50 percent reduction in such fees for small entities that qualify for reduced fees under section 41(h)(1).
35 U.S.C. § 151 - Issue of Patent
(a) IN GENERAL.—If it appears that an applicant is entitled to a patent under the law, a written notice of allowance of the application shall be given or mailed to the applicant. The notice shall specify a sum, constituting the issue fee and any required publication fee, which shall be paid within 3 months thereafter.
(b) EFFECT OF PAYMENT.—Upon payment of this sum the patent may issue, but if payment is not timely made, the application shall be regarded as abandoned.
35 U.S.C. § 154 - Contents and Term of Patent; Provisional Rights
(a) IN GENERAL.—
(1) CONTENTS.—Every patent shall contain a short title of the invention and a grant to the patentee, his heirs or assigns, of the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States, and, if the invention is a process, of the right to exclude others from using, offering for sale or selling throughout the United States, or importing into the United States, products made by that process, referring to the specification for the particulars thereof.
(2) TERM.—Subject to the payment of fees under this title, such grant shall be for a term beginning on the date on which the patent issues and ending 20 years from the date on which the application for the patent was filed in the United States or, if the application contains a specific reference to an earlier filed application or applications under section 120, 121, 365(c), or 386(c), from the date on which the earliest such application was filed.
(3) PRIORITY.—Priority under section 119, 365(a), 365(b), 386(a), or 386(b) shall not be taken into account in determining the term of a patent.
37 CFR § 1.56 - Duty to Disclose Information Material to Patentability
(a) A patent by its very nature is affected with a public interest. The public interest is best served, and the most effective patent examination occurs when, at the time an application is being examined, the Office is aware of and evaluates the teachings of all information material to patentability. Each individual associated with the filing and prosecution of a patent application has a duty of candor and good faith in dealing with the Office, which includes a duty to disclose to the Office all information known to that individual to be material to patentability as defined in this section. The duty to disclose information exists with respect to each pending claim until the claim is cancelled or withdrawn from consideration, or the application becomes abandoned. Information material to the patentability of a claim that is cancelled or withdrawn from consideration need not be submitted if the information is not material to the patentability of any claim remaining under consideration in the application. There is no duty to submit information which is not material to the patentability of any existing claim. The duty to disclose all information known to be material to patentability is deemed to be satisfied if all information known to be material to patentability of any claim issued in a patent was cited by the Office or submitted to the Office in the manner prescribed by §§ 1.97(b)-(d) and 1.98. However, no patent will be granted on an application in connection with which fraud on the Office was practiced or attempted or the duty of disclosure was violated through bad faith or intentional misconduct. The Office encourages applicants to carefully examine:
(1) Prior art cited in search reports of a foreign patent office in a counterpart application, and
(2) The closest information over which individuals associated with the filing or prosecution of a patent application believe any pending claim patentably defines, to make sure that any material information contained therein is disclosed to the Office.
(b) Under this section, information is material to patentability when it is not cumulative to information already of record or being made of record in the application, and
(1) It establishes, by itself or in combination with other information, a prima facie case of unpatentability of a claim; or
(2) It refutes, or is inconsistent with, a position the applicant takes in:
(i) Opposing an argument of unpatentability relied on by the Office, or
(ii) Asserting an argument of patentability.
A prima facie case of unpatentability is established when the information compels a conclusion that a claim is unpatentable under the preponderance of evidence, burden-of-proof standard, giving each term in the claim its broadest reasonable construction consistent with the specification, and before any consideration is given to evidence which may be submitted in an attempt to establish a contrary conclusion of patentability.
STATUTORY REFERENCE INDEX
Primary Statutes Taught in Chapter 3:
- 35 U.S.C. § 131 - Examination of Application
- 35 U.S.C. § 132 - Notice of Rejection; Reexamination
- 35 U.S.C. § 151 - Issue of Patent (Notice of Allowance)
- 35 U.S.C. § 154 - Contents and Term of Patent
- 37 CFR § 1.56 - Duty to Disclose Material Information
- MPEP § 713 - Examiner Interviews
- MPEP § 2001 - Duty of Disclosure
Related Concepts:
- Technology Center organization and assignment
- Broadest Reasonable Interpretation (BRI) claim construction
- Ex parte examination procedures
- Prosecution history estoppel
- Inequitable conduct doctrine (*Therasense* standard)